BIOLOGICAL ACTIONS OF CHOLECYSTOKININ

被引:604
作者
CRAWLEY, JN
CORWIN, RL
机构
[1] Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda
关键词
CHOLECYSTOKININ; NEUROPEPTIDE; SYNTHESIS; METABOLISM; RECEPTORS; RELEASE; GENETICS; ANATOMY; NEUROPHYSIOLOGY; DIGESTION; CARDIOVASCULAR; RESPIRATION; TEMPERATURE; SLEEP; NEUROTOXICITY; EPILEPSY; LUNG CANCER; FEEDING; SATIETY; APPETITE; DOPAMINE; SCHIZOPHRENIA; SELF-STIMULATION; DRUG ABUSE; PAIN; MEMORY; ANXIETY; PANIC; MENTAL ILLNESS;
D O I
10.1016/0196-9781(94)90104-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholecystokinin (CCK) has emerged as an important mammalian neuropeptide, localized in peripheral organs and in the central nervous system. This review presents an overview of the molecular aspects of CCK peptides and CCK receptors, the anatomical distribution of CCK, the neurophysiological actions of CCK, release of CCK and effects of CCK on release of other neurotransmitters, and the actions of CCK on digestion, feeding, cardiovascular function, respiratory function, neurotoxicity and seizures, cancer cell proliferation, analgesia, sleep, sexual and reproductive behaviors, memory, anxiety, and dopamine-mediated exploratory and rewarded behaviors. Human clinical studies of CCK in feeding disorders and panic disorders are described. New findings are presented on potent, nonpeptide CCK antagonists, selective for the two CCK receptor subtypes, which demonstrate that endogenous CCK has biologically important effects on physiology and behavior. © 1994.
引用
收藏
页码:731 / 755
页数:25
相关论文
共 550 条
  • [1] ABELSON JL, 1990, ARCH GEN PSYCHIAT, V47, P395
  • [2] INTERACTION OF THE CHOLINERGIC SYSTEM AND CHOLECYSTOKININ IN THE REGULATION OF ENDOGENOUS AND EXOGENOUS STIMULATION OF PANCREATIC-SECRETION IN HUMANS
    ADLER, G
    BEGLINGER, C
    BRAUN, U
    REINSHAGEN, M
    KOOP, I
    SCHAFMAYER, A
    ROVATI, L
    ARNOLD, R
    [J]. GASTROENTEROLOGY, 1991, 100 (02) : 537 - 543
  • [3] ADLER G, 1988, DIGESTION, V40, P67
  • [4] ADRIAN TE, 1988, FASEB J, V2, pA737
  • [5] CHOLECYSTOKININ-INDUCED PROTECTION OF CULTURED CORTICAL-NEURONS AGAINST GLUTAMATE NEUROTOXICITY
    AKAIKE, A
    TAMURA, Y
    SATO, Y
    OZAKI, K
    MATSUOKA, R
    MIURA, S
    YOSHINAGA, T
    [J]. BRAIN RESEARCH, 1991, 557 (1-2) : 303 - 307
  • [6] CHOLECYSTOKININ
    ALBUS, M
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 : S5 - S21
  • [7] CHOLECYSTOKININ ATTENUATES BASAL AND DRUG-INDUCED INCREASES OF LIMBIC AND STRIATAL DOPAMINE RELEASE
    ALTAR, CA
    BOYAR, WC
    OEI, E
    WOOD, PL
    [J]. BRAIN RESEARCH, 1988, 460 (01) : 76 - 82
  • [8] EFFECTS OF CHOLECYSTOKININ AND CERULEIN ON GASTRIC-EMPTYING
    ANIKA, MS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 85 (02) : 195 - 199
  • [9] CHOLECYSTOKININ ELICITS COMPLETE BEHAVIORAL SEQUENCE OF SATIETY IN RATS
    ANTIN, J
    GIBBS, J
    HOLT, J
    YOUNG, RC
    SMITH, GP
    [J]. JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1975, 89 (07): : 784 - 790
  • [10] SOMATOSTATIN AND CCK-8 MODULATE RELEASE OF STRIATAL AMINO-ACIDS - ROLE OF DOPAMINE-RECEPTORS
    ARNERIC, SP
    MEELEY, MP
    REIS, DJ
    [J]. PEPTIDES, 1986, 7 (01) : 97 - 103